» Authors » Valentina Condelli

Valentina Condelli

Explore the profile of Valentina Condelli including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 497
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirra P, Parascandolo A, Marino G, DAlterio F, Zinna L, Desiderio A, et al.
Mol Med . 2024 Nov; 30(1):201. PMID: 39501160
The adipose tissue (AT) surrounding breast cancer (BC) plays a pivotal role in cancer progression and represents an optimal source for new biomarker discovery. The aim of this work was...
2.
Caruso F, Dandrea M, Coppola L, Landriscina M, Condelli V, Cerulo L, et al.
Cancer Cell Int . 2022 Aug; 22(1):253. PMID: 35953834
In addition to being novel biomarkers for poor cancer prognosis, members of Lymphocyte antigen-6 (Ly6) gene family also play a crucial role in avoiding immune responses to tumors. However, it...
3.
Bruno G, Li Bergolis V, Piscazzi A, Crispo F, Condelli V, Zoppoli P, et al.
Int J Oncol . 2022 May; 60(6). PMID: 35543151
Metabolic rewiring fuels rapid cancer cell proliferation by promoting adjustments in energetic resources, and increasing glucose uptake and its conversion into lactate, even in the presence of oxygen. Furthermore, solid...
4.
Piscazzi A, Condelli V, Crispo F, Coda A, Calice G, Bruno G, et al.
Oncol Lett . 2022 May; 23(6):185. PMID: 35527787
Insulin-like growth factor binding protein 6 (IGFBP6) is a secreted protein with a controversial role in human malignancies, being downregulated in most types of human cancer, but upregulated in selected...
5.
Condelli V, Calice G, Cassano A, Basso M, Rodriquenz M, Zupa A, et al.
Cancers (Basel) . 2021 Jan; 13(1). PMID: 33466447
Epigenetics is involved in tumor progression and drug resistance in human colorectal carcinoma (CRC). This study addressed the hypothesis that the DNA methylation profiling may predict the clinical behavior of...
6.
Lettini G, Condelli V, Pietrafesa M, Crispo F, Zoppoli P, Maddalena F, et al.
Int J Mol Sci . 2020 Oct; 21(20). PMID: 33065966
Wnt/β-Catenin signaling is involved in embryonic development, regeneration, and cellular differentiation and is responsible for cancer stemness maintenance. The HSP90 molecular chaperone TRAP1 is upregulated in 60-70% of human colorectal...
7.
Maddalena F, Condelli V, Matassa D, Pacelli C, Scrima R, Lettini G, et al.
Mol Oncol . 2020 Oct; 14(12):3030-3047. PMID: 33025742
Metabolic rewiring is a mechanism of adaptation to unfavorable environmental conditions and tumor progression. TRAP1 is an HSP90 molecular chaperone upregulated in human colorectal carcinomas (CRCs) and responsible for downregulation...
8.
Crispo F, Pietrafesa M, Condelli V, Maddalena F, Bruno G, Piscazzi A, et al.
Molecules . 2020 Aug; 25(16). PMID: 32824685
Cholangiocarcinoma is a primary malignancy of the biliary tract characterized by late and unspecific symptoms, unfavorable prognosis, and few treatment options. The advent of next-generation sequencing has revealed potential targetable...
9.
Lepore S, Lettini G, Condelli V, Sisinni L, Piscazzi A, Simeon V, et al.
Int J Med Sci . 2020 Jan; 17(1):112-124. PMID: 31929745
HPV-positive oral squamous cell carcinomas (OSCCs) are specific biological and clinical entities, characterized by a more favorable prognosis compared to HPV-negative OSCCs and occurring generally in non-smoking and non-drinking younger...
10.
Pietrafesa M, Maddalena F, Possidente L, Condelli V, Zoppoli P, Li Bergolis V, et al.
Int J Mol Sci . 2019 Dec; 21(1). PMID: 31878280
Tumor Necrosis Factor Receptor-Associated Protein 1 (TRAP1) is a heat shock protein 90 (HSP90) molecular chaperone overexpressed in 60-70% human colorectal carcinomas (CRCs) and the co-upregulation of TRAP1 and associated...